RR Series — Research Grants

NIH R03 Grants — Small Research Grant

Reviewed by Dr. Meng ZhaoLast reviewed June 9, 2026Data refreshed June 9, 2026Editorial standards

Small, short-term projects (pilot studies, secondary analyses, methods development)

Funding

Up to $50,000 direct costs per year

Duration

Up to 2 years

Eligibility

Any qualified investigator

Activity code

R03

What is the NIH R03 grant?

The R03 is the NIH Small Research Grant — a focused 2-year award capped at $50,000 in direct costs per year. It is designed for small, well-defined projects: pilot studies, secondary analyses of existing data, methods development, or short studies that can be completed in 2 years. Not all NIH institutes participate in the R03 program.

Recent R03 awards from NIH RePORTER

Examples of funded R03 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on June 9, 2026.

Matching awards (last 2 FYs)
865
Full matching record count on RePORTER
Sampled funding
$77.3M
Sum of award amounts in the sample
Average award
$155K
Mean award amount in the sample

Example R03 projects from the sample

  • Immune evasive mouse models for transplantation research

    1R03AI196408-01
    Deepta Bhattacharya · UNIVERSITY OF ARIZONA, AZ · $155,479 · awarded Jun 4, 2026 · NIH

    Abstract: Decades of research on transplantation have made it clear that the immunological barriers to engraftment are substantial. The goal of this proposal is to generate transgenic mouse models that will allow standardized and orthogonal testing of pathways important for overcoming transplantation barriers, and through this work, instruct efforts in…

  • Identification and Characterization of Mutation-Induced Alternative Splicing Events in Cancer Using Multi-Omics Data

    1R03CA313545-01
    Song Cao · WASHINGTON UNIVERSITY, MO · $155,500 · awarded Jun 3, 2026 · NIH

    Identification and Characterization of Mutation-Induced Alternative Splicing Events in Cancer Using Multi-Omics Data Project Summary The goal of this project is to discover mutation-induced alternative splicing events (MAS), understand their functional relevance, and identify neoantigens arising from these events to advance cancer immunotherapy. Large-scale…

  • Enhancing Personal Air Pollution Exposure Data for Mechanistic Health Research

    1R03ES038687-01
    Ryan Chartier · RESEARCH TRIANGLE INSTITUTE, NC · $221,941 · awarded Jun 3, 2026 · NIH

    PROJECT SUMMARY/ABSTRACT Exposure to fine particulate matter (PM2.5) is a leading global environmental health risk, contributing to millions of premature deaths annually. However, conventional exposure assessments often rely on mass- based metrics that fail to capture critical particle characteristics such as size distribution, which influences respiratory…

  • Defining long-term sequelae and humoral immunity in Sudan ebolavirus survivors

    1R03AI197002-01
    Bronwyn Gunn · WASHINGTON STATE UNIVERSITY, WA · $76,500 · awarded Jun 3, 2026 · NIH

    PROJECT SUMMARY Uganda has experienced seven outbreaks of the highly pathogenic orthoebolavirus, Sudan virus (SUDV) since 2000. SUDV has reemerged in Uganda twice since September 2022 - first with an outbreak with 142 confirmed cases and 55 known deaths between September-December 2022, and again in January 2025, with 9 confirmed cases and 1 death as of…

  • Investigation of RASopathy variants and Raf and Actin-Myosin regulation

    1R03HD121999-01
    Claire de la Cova · UNIVERSITY OF WISCONSIN MILWAUKEE, WI · $144,064 · awarded Jun 2, 2026 · NIH

    Project Summary This proposal aims to discover insights into how pathogenic, RASopathy-associated genetic variants of human BRAF and RAF1 genes alter Raf protein and the Actin-Myosin cytoskeleton. Our work in Caenorhabditis elegans produced a collection of strains with Raf variants modeled on those found in human the RASopathy disorders Noonan syndrome and…

  • Surface EMG-driven home exercise program for postoperative rehabilitation after peripheral nerve injuries

    1R03HD120500-01
    Yusha Liu · UNIVERSITY OF WASHINGTON, WA · $324,875 · awarded Jun 2, 2026 · NIH

    Abstract Brachial plexus and other peripheral nerve injuries often lead to severe functional impairments, with impacts on one's independence and quality of life. Nerve reconstruction surgeries offer the best chance for restoring motor function, however, return of muscle strength occurs slowly over the course of 1-2 years. Rehabilitation and hand/physical…

  • The impact of chronic low dose cadmium exposure on skeletal growth and maintenance in mice models

    1R03HD122165-01
    Sadaf Dabeer · EMORY UNIVERSITY, GA · $156,500 · awarded Jun 1, 2026 · NIH

    PROJECT SUMMARY/ABSTRACT Osteoporosis is a debilitating skeletal disease affecting over 50% of women and 25% of men over the age of 50, often resulting in painful and disabling fractures that significantly reduce quality of life and increase mortality. Achieving optimal peak bone mass and strength during early life is one of the most critical factors in…

  • Genetic characterization of MesV sensory cells in normal development and in the neurodegenerative disease spinal muscular atrophy

    1R03DE036052-01
    Danny Florez Paz · COLUMBIA UNIVERSITY HEALTH SCIENCES, NY · $329,000 · awarded Jun 1, 2026 · NIH

    Project summary Proper feeding behavior during early postnatal development is essential for survival, relying on a seamless transition from suckling to mastication as cranial sensory-motor circuits mature. In mammals, orofacial movements required for nutrient intake depend on the coordinated development of specific motor and sensory pathways, yet the…

  • Manipulating PIWI-interacting RNA to generate sterile ticks

    1R03AI199321-01
    Shahid Karim · UNIVERSITY OF SOUTHERN MISSISSIPPI, MS · $150,000 · awarded Jun 1, 2026 · NIH

    SUMMARY The Piwi-interacting RNA (piRNA) pathway is a conserved genome surveillance mechanism essential for germline integrity and fertility in invertebrates, including ticks. Piwi (P-element Induced Wimpy Testis) proteins play a critical role in silencing transposable elements (TEs) to preserve genome stability in germ cells. Our preliminary data shows…

  • Impact of Transcutaneous Spinal Stimulation on Blood Pressure and Orthostasis in Spinal Cord Injury: Short and Long-Term Effects

    1R03HD120505-01
    Einat Haber · KESSLER FOUNDATION, INC., NJ · $281,114 · awarded May 28, 2026 · NIH

    Individuals with a spinal cord injury (SCI) in the cervical or high thoracic (≥T6) regions often experience unstable low blood pressure (BP) and orthostatic hypotension (OH), a sudden BP drop upon moving to an upright position. OH can cause dizziness, blurred vision, syncope, and falls, negatively impacting quality of life (QOL) and increasing long-term…

  • Understanding the role of TB disclosure and stigma in the context of TB care

    1R03HL183275-01
    Colleen Hanrahan · JOHNS HOPKINS UNIVERSITY, MD · $194,094 · awarded May 28, 2026 · NIH

    PROJECT SUMMARY Tuberculosis (TB) is a global health emergency and is a major cause of morbidity and mortality worldwide. As a social determinant of health, stigma associated with TB affects those with the disease, their families and communities. TB stigma is prevalent, with global estimates ranging from 25-80% of people with TB experiencing TB stigma. It…

  • Develop a human pluripotent stem cell-derived preclinical model for NUT Carcinoma

    1R03CA313287-01
    Bin Gu · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES, MI · $157,000 · awarded May 26, 2026 · NIH

    Title: Develop a human pluripotent stem cell-derived preclinical model for NUT Carcinoma Project Summary: NUT Carcinoma (NC) is a devastating cancer with no effective treatment. A deeper understanding of its oncogenesis mechanism is vital for developing treatments that improve its prognosis. Although NC cases are strongly associated with Nuclear Protein in…

Funding institutes in the sample

InstituteAwardsFunding
NIH500$77.3M

Most frequent institutions in the sample

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES 13 awards
  2. UNIVERSITY OF PITTSBURGH AT PITTSBURGH 13 awards
  3. UNIVERSITY OF MICHIGAN AT ANN ARBOR 10 awards
  4. MASSACHUSETTS GENERAL HOSPITAL 10 awards
  5. BAYLOR COLLEGE OF MEDICINE 10 awards
  6. JOHNS HOPKINS UNIVERSITY 10 awards
  7. UNIVERSITY OF COLORADO DENVER 9 awards
  8. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 9 awards

Source: NIH RePORTER. Verify any award in the official record by searching its project number. See our data methodology for how this sample is built and its limitations.

Decision guide

Choose R03 when

Choose R03 when your project is small, focused, and finishable in 2 years on a $50K/year budget. Good fits include secondary analyses of public datasets, pilot work to support a future R01, or methods comparisons.

Choose another mechanism when

Skip R03 if your project needs more than $50K/year, more than 2 years, or doesn't have a clearly bounded scope. Pick R21 for exploratory work needing $275K total over 2 years.

Who applies for R03

R03 applicants span the full career range. New investigators sometimes use R03 as a low-stakes entry into NIH funding. Established investigators use R03s to fund discrete side projects or pilot work that will support a future R01.

Compare nearby NIH grant mechanisms

Searchers often land on R03 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.

For broad grant lookup, use the NIH grant search to find funded examples by activity code, PI, institution, and award year.

Search tips for R03

  • R03 awards often precede a related R01 from the same investigator — useful for tracking emerging research lines.
  • Some institutes (e.g., NIA, NIDCR) participate heavily in R03; others rarely do.

Search NIH grants by activity code

Find R03-funded PIs

R03 funding trends

R03 frequently asked questions

What is the page limit for an R03?

The Research Strategy is 6 pages for an R03 (compared to 12 pages for an R01).

Can R03 grants be renewed?

R03 awards are not renewable. Once the 2-year project period ends, you cannot apply for a continuation. You must move to a different mechanism (R21, R01, etc.).

Related NIH grant types